日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

plasmaMATCH试验中ctDNA水平对晚期乳腺癌患者的预后和预测影响

Browne, Iseult M; Pascual, Javier; Cutts, Rosalind J; Kingston, Belinda; Hrebien, Sarah; Kilburn, Lucy S; Pearson, Alex; Moretti, Laura; Wardley, Andrew M; Macpherson, Iain R; Baird, Richard D; Roylance, Rebecca; Gil-Gil, Miguel J; Guerrero-Zotano, Ángel L; Garcia-Murillas, Isaac; Bliss, Judith M; Ring, Alistair; Martín, Miguel; Turner, Nicholas C

Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.

BRCA1 和 BRCA2 相关乳腺癌的新辅助 PARP 抑制剂治疗方案:PARTNER,一项随机 II/III 期试验

Abraham Jean E, O'Connor Lenka Oplustil, Grybowicz Louise, Alba Karen Pinilla, Dayimu Alimu, Demiris Nikolaos, Harvey Caron, Drewett Lynsey M, Lucey Rebecca, Fulton Alexander, Roberts Anne N, Worley Joanna R, Chhabra Ms Anita, Qian Wendi, Brown Jessica, Hardy Richard, Vallier Anne-Laure, Chan Steve, Cidon Maria Esther Una, Sherwin Elizabeth, Chakrabarti Amitabha, Sadler Claire, Barnes Jen, Persic Mojca, Smith Sarah, Raj Sanjay, Borley Annabel, Braybrooke Jeremy P, Staples Emma, Scott Lucy C, Palmer Cheryl A, Moody Margaret, Churn Mark J, Pilger Domenic, Zagnoli-Vieira Guido, Wijnhoven Paul W G, Mukesh Mukesh B, Roylance Rebecca R, Schouten Philip C, Levitt Nicola C, McAdam Karen, Armstrong Anne C, Copson Ellen R, McMurtry Emma, Galbraith Susan, Tischkowitz Marc, Provenzano Elena, O'Connor Mark J, Earl Helena M

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease

乳腺癌多基因风险评分与原位乳腺疾病后的预后相关

Timbres, Jasmine; Kohut, Kelly; Mavaddat, Nasim; Easton, Douglas F; Petridis, Christos; Roylance, Rebecca; Schmidt, Marjanka K; Sawyer, Elinor J

Exploring the Social Validity and Diffusion Potential of Common Naturalistic Developmental Behavioral Intervention Strategies Implemented in Community Preschools

探索在社区幼儿园实施的常见自然情境下发展行为干预策略的社会有效性和推广潜力

D'Agostino, Sophia R; Landon, Trenton J; Roylance, Alyssa; Briggs, Avery; Bhana-Lopez, Naima

HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction

HER-SAFE 研究设计:一项开放标签、随机对照试验,旨在研究停止药物治疗对已恢复的 HER2 靶向治疗相关心脏功能障碍患者的安全性。

Dowsing, Benjamin; Dehbi, Hakim-Moulay; Chung, Robin; Pedra, Joanna; Worn, Orla; Artico, Jessica; Schmid, Peter; Roylance, Rebecca; Kellman, Peter; Moon, James C; Crake, Tom; Westwood, Mark; Ghosh, Arjun; Andres, Maria Sol; Nazir, Muhummad Sohaib; Lyon, Alexander R; Chen, Daniel; Walker, Malcolm; Manisty, Charlotte H

The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol

超低剂量FDG-PET显像在妊娠相关乳腺癌中的安全性和临床意义:英国一家大型三级肿瘤转诊中心的经验及建议的显像方案

Desouza, Karen; Fessas, Petros; Spurrell, Emma; Papadimitraki, Elisavet; Raja, Fharat; Roylance, Rebecca; Ottaviani, Diego; Franks, Joanna; Betal, Dibendu; Babar, Mahwash; Athanasiou, Irene; Cariati, Massimilano; Patani, Neill; Hadad, Sirwan; Kayani, Yusuf; Walls, Darren; Scott, Catherine; Rega, Marilena; Arshad, Mubarik; Bomanji, Jamshed; Vöö, Stefan

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ALTTO 试验的最终分析:曲妥珠单抗序贯或联合拉帕替尼治疗 HER2 阳性早期乳腺癌患者 [BIG 2-06/NCCTG N063D (Alliance)]

de Azambuja, E; Piccart-Gebhart, M; Fielding, S; Townend, J; Hillman, D W; Colleoni, M; Roylance, R; Kelly, C M; Lombard, J; El-Abed, S; Choudhury, A; Korde, L; Vicente, M; Chumsri, S; Rodeheffer, R; Ellard, S L; Wolff, A C; Holtschmidt, J; Lang, I; Untch, M; Boyle, F; Xu, B; Werutsky, G; Tujakowski, J; Huang, C-S; Baruch, N B; Bliss, J; Ferro, A; Gralow, J; Kim, S-B; Kroep, J R; Krop, I; Kuemmel, S; McConnell, R; Moscetti, L; Knop, A S; van Duijnhoven, F; Gomez, H; Cameron, D; Di Cosimo, S; Gelber, R D; Moreno-Aspitia, A

Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial

一项实用性随机对照试验的研究方案,旨在比较在癌症幸存者或康复者中,在常规后续护理基础上增加强化接受与承诺疗法(+)与仅进行常规后续护理的效果:癌症幸存者康复评估(SURECAN)试验

Khan, Imran; Taylor, Stephanie J C; Robinson, Clare; Moschopoulou, Elisavet; McCrone, Paul; Bourke, Liam; Thaha, Mohamed; Bhui, Kamaldeep; Rosario, Derek; Ridge, Damien; Donovan, Sheila; Korszun, Ania; Little, Paul; Morgan, Adrienne; Quentin, Olivier; Roylance, Rebecca; White, Peter; Chalder, Trudie

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation

SARS-CoV-2 刺突蛋白抗体疫苗反应与癌症患者感染严重程度的关联:一项全国性 COVID 癌症横断面评估

Lee, Lennard Y W; Tilby, Michael; Starkey, Thomas; Ionescu, Maria C; Burnett, Alex; Hattersley, Rosie; Khan, Sam; Little, Martin; Liu, Justin K H; Platt, James R; Tripathy, Arvind; Watts, Isabella; Williams, Sophie Therese; Appanna, Nathan; Al-Hajji, Youssra; Barnard, Matthew; Benny, Liza; Buckley, Andrew; Cattell, Emma; Cheng, Vinton; Clark, James; Eastlake, Leonie; Gerrand, Kate; Ghafoor, Qamar; Grumett, Simon; Harper-Wynne, Catherine; Kahn, Rachel; Lee, Alvin J X; Lydon, Anna; McKenzie, Hayley; Panneerselvam, Hari; Pascoe, Jennifer; Patel, Grisma; Patel, Vijay; Potter, Vanessa; Randle, Amelia; Rigg, Anne S; Robinson, Tim; Roylance, Rebecca; Roques, Tom; Rozmanowski, Stefan; Roux, René L; Shah, Ketan; Sintler, Martin; Taylor, Harriet; Tillett, Tania; Tuthill, Mark; Williams, Sarah; Beggs, Andrew; Iveson, Tim; Lee, Siow Ming; Middleton, Gary; Middleton, Mark; Protheroe, Andrew S; Fittall, Matthew W; Fowler, Tom; Johnson, Peter

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

奥拉帕尼和塞拉塞替(AZD6738)治疗三阴性晚期乳腺癌患者:plasmaMATCH试验E组的结果(CRUK/15/010)

Ring, Alistair; Kilburn, Lucy S; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew M; Gurel, Bora; Macpherson, Iain R; Riisnaes, Ruth; Baird, Richard D; Martin, Sue; Roylance, Rebecca; Johnson, Hannah; Ferreira, Ana; Winter, Matthew C; Dunne, Kathryn; Copson, Ellen; Hickish, Tamas; Burcombe, Russell; Randle, Kat; Serra, Violeta; Llop-Guevara, Alba; Bliss, Judith M; Turner, Nicolas C